Avient vs DuPont de Nemours
AVNT and DD side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AVNT and DD compare
DuPont de Nemours is the larger company, worth 4.8 times as much as Avient ($19.0B against $3.9B).
On earnings, Avient is cheaper: it trades at 23.2× trailing earnings, against 312× for DuPont de Nemours.
DuPont de Nemours grew revenue faster over the last twelve months (3.3% versus 2.4% for Avient).
Avient keeps more of each dollar of sales as profit, with a net margin of 5.1% compared with 0.79% at DuPont de Nemours.
Both pay dividends: Avient yields 2.6% and DuPont de Nemours 1.7%.
Avient scores higher on the StockData Score (12 against 10 for DuPont de Nemours), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AVNT | DD |
|---|---|---|
| Size and price | ||
| Market cap | $3.9B | $19.0B |
| Share price | $42.84 | $140.58 |
| Change, 1 year | 34.3% | −42.8% |
| Change, 5 years | −26.0% | −41.7% |
| Beta (5Y) | 1.36 | 1.16 |
| Employees | 9,000 | 15K |
| StockData Score | ||
| Total score | 12 (better) | 10 |
| Valuation score | 2 (better) | 1 |
| Growth score | 2 | 3 (better) |
| Performance score | 2 (better) | 0 |
| Health score | 2 | 4 (better) |
| Dividend score | 4 (better) | 2 |
| Valuation | ||
| P/E | 23.2× (better) | 312× |
| P/S | 1.2× (better) | 2.7× |
| P/B | 1.6× | 1.4× (better) |
| EV/EBITDA | 10.7× (better) | 22.4× |
| P/FCF | 20.6× (better) | 27.0× |
| FCF yield | 4.9% (better) | 3.7% |
| Fair value | $48.97 | $95.49 |
| Margin of safety | 12.5% (better) | −47.2% |
| Growth | ||
| Revenue growth (TTM) | 2.4% | 3.3% (better) |
| Revenue growth, 5Y average | 8.0% (better) | −9.3% |
| Net income growth (TTM) | 43.0% | – |
| EPS growth (TTM) | 43.4% | – |
| EPS growth, 5Y average | −9.3% | – |
| Profitability | ||
| Gross margin | 31.7% | 35.1% (better) |
| Operating margin | 9.5% | – |
| Net margin | 5.1% (better) | 0.79% |
| FCF margin | 5.7% | 10.0% (better) |
| Return on equity | 7.1% (better) | 0.30% |
| Return on invested capital | 6.1% | – |
| Financial health | ||
| Debt / equity | 0.77 | 0.23 (better) |
| Net debt / EBITDA | 2.87 | 1.52 (better) |
| Current ratio | 1.90 | 2.43 (better) |
| Altman Z-score | 1.54 (better) | 0.46 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 2.6% (better) | 1.7% |
| Payout ratio | 58.7% | 758% |
| Years of dividend growth | 15 (better) | 0 |
| Dividend growth, 5Y average | 5.8% (better) | 3.6% |
| Buyback yield | – | −0.71% |
| Shareholder yield | 2.6% (better) | 1.00% |
| Ownership | ||
| Held by institutions | 105% | 73.7% |
| Held by insiders | 0.86% | 0.95% |
| Insider net buying, 12 months | – | −$607K |
| Short interest, % of float | 5.1% | 3.8% |
Go deeper
- AVNT stock overview
- AVNT income statement
- AVNT valuation and score
- DD stock overview
- DD income statement
- DD valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.